Use of traditional Chinese medicine in the treatment of immune-related adverse events of cancer immunotherapy
Immune checkpoint inhibitors (ICPI) have shown considerable promise in the treatment of tumors. However, immune-related adverse events (irAEs) caused by ICPI have been reported in nearly every organ system. Whilst this represents a new challenge in the field of cancer treatment, traditional Chinese...
Main Authors: | Li Hou, Liya Ju, Jing Wang, Tian Zhou, Yang Shen, Jiaqi Chi, Jean-Pierre Armand, Anlong Xu, Kaiwen Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-10-01
|
Series: | Journal of Traditional Chinese Medical Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2095754817301126 |
Similar Items
-
Modern immunology is crucial to revealing the biological mechanisms of traditional Chinese medicine
by: Liya Ju, et al.
Published: (2023-10-01) -
The development of traditional Chinese medicine
by: Danning Ma, et al.
Published: (2021-11-01) -
Traditional medicine is the valuable resource for global health
by: Anlong Xu
Published: (2021-01-01) -
Active ingredients of traditional Chinese medicine for enhancing the effect of tumor immunotherapy
by: Chao Yang, et al.
Published: (2023-03-01) -
Adverse Events of Oncologic Immunotherapy and Their Management
by: Fedricker Diane Barber
Published: (2019-01-01)